Morningstar

Amgen Says Proprietary Data, Patient Health Info Were Exfiltrated in Cyber Incident

Provided by Dow Jones

By Elias Schisgall

Amgen said proprietary data and protected patient health information were exfiltrated from a cloud environment in a cybersecurity incident this month.

The biotechnology company's data was exfiltrated from a cloud environment hosted by a third-party provider, according to a Friday filing with the Securities and Exchange Commission. The company deemed it a material incident due to the volume and potential sensitivity of impacted files.

Amgen said that its investigation, which is still ongoing, has not identified any impact to its products, financial reports, manufacturing, or ability to meet patient needs.

The company said that it doesn't currently believe that the incident will have a material impact on its results or financial conditions.

Amgen is slated to release its second-quarter results after the market closes on Tuesday.

Write to Elias Schisgall at elias.schisgall@wsj.com




  (END) Dow Jones Newswires



  July 31, 2026 16:41 ET (20:41 GMT)


Copyright (c) 2026 Dow Jones & Company, Inc.
  

					The articles, information, and content displayed on this webpage may
					include materials prepared and provided by third parties. Such
					third-party content is offered for informational purposes only and
					is not endorsed, reviewed, or verified by Morningstar.
				
 

					Morningstar makes no representations or warranties regarding the
					accuracy, completeness, timeliness, or reliability of any third-party
					content displayed on this site. The views and opinions expressed in
					third-party content are those of the respective authors and do not
					necessarily reflect the views of Morningstar, its affiliates, or employees.
				
 

					Morningstar is not responsible for any errors, omissions, or delays
					in this content, nor for any actions taken in reliance thereon.
					Users are advised to exercise their own judgment and seek independent
					financial advice before making any decisions based on such content.
					The third-party providers of this content are not affiliated with
					Morningstar, and their inclusion on this site does not imply any
					form of partnership, agency, or endorsement.
				
 

				Popular
				
 
  
 
 
 
 
4 Stocks to Buy for the Long-Term While They’re Still Undervalued
 
Plus, a deep dive on SpaceX’s bid to challenge US telecoms. 
 
 
David Sekera, CFA and Sarah Hansen 
 
 
 
Why This Vanguard ETF Is One of the Best
 
Vanguard Total International Stock is appealing for several reasons. 
 
 
Zachary Evens 
 
 
 
6 ETFs To Diversify Away From AI
 
A difficult problem has an easy solution. 
 
 
Daniel Sotiroff 
 
 
 
The Best AI Stocks to Buy Now
 
Artificial intelligence stocks continue to attract investors, thanks to industry momentum and appealing valuations. 
 
 
Tori Brovet 
 
 
 
2 Undervalued Stocks to Buy With Long-Term Growth Ahead
 
Defense spending and booming data center demand could provide powerful tailwinds for these 4-star stocks. 
 
 
David Sekera, CFA, Sarah Hansen, and Jess Bebel 
 
 
 
 

			Sponsor Center